8-KMaterial AgreementsOther EventsExhibits & Filings

CME GROUP INC. 8-K Report, Material Agreement (May 11, 2007)

Filed May 11, 2007For Securities:CME

Summary

CME Group Inc. (CME) filed an 8-K on May 11, 2007, detailing significant amendments to its merger agreement with CBOT Holdings, Inc. The most crucial update for investors is the revised exchange ratio for the merger, where CBOT Holdings Class A stockholders will now receive 0.3500 shares of CME Holdings Class A common stock for each share they own. This adjustment directly impacts the valuation and ownership structure post-merger. Furthermore, the amendment increases the termination fee to $288 million, signaling a higher commitment or potential cost associated with the deal's dissolution. The filing also discloses CME Group's intention to launch a substantial cash tender offer of up to $3.5 billion for common stock of the combined entity at a fixed price of $560 per share, shortly after the merger's completion. This tender offer is a key event for existing CME shareholders and potential arbitrageurs.

Key Highlights

  • 1CME Group Inc. amended its merger agreement with CBOT Holdings, Inc. on May 11, 2007.
  • 2The exchange ratio for the merger was adjusted: CBOT Holdings Class A stockholders will receive 0.3500 shares of CME Holdings Class A common stock per share.
  • 3The termination fee for the merger agreement has been increased to $288 million.
  • 4Following the merger, CME Group plans to initiate a cash tender offer for up to $3.5 billion of the combined company's common stock.
  • 5The tender offer will be conducted at a fixed price of $560 per share.
  • 6This filing constitutes notification of a material definitive agreement related to the merger.

Frequently Asked Questions

Following the amendment, for each share of CBOT Holdings Class A common stock, CBOT Holdings Class A stockholders will be entitled to receive 0.3500 shares of CME Holdings Class A common stock.

The termination fee, as defined in the Merger Agreement, has been increased to $288 million.

CME Group intends to commence a cash tender offer for up to $3.5 billion in common stock of the combined company at a fixed price of $560 per share, following the completion of the merger.

This 8-K filing is significant because it announces material changes to the terms of the pending merger between CME and CBOT, including the share exchange ratio and the termination fee. It also signals a significant capital allocation plan through a large post-merger tender offer, which could impact share prices and provide liquidity for existing shareholders.